Latest Competition News

EVZ Limited has issued earnings guidance for the first half of FY2025, forecasting revenue between $53 million and $55 million and EBITDA ranging from $2.4 million to $2.6 million based on preliminary figures.

EVZ Limited reported a robust $3.2 million net positive operating cash inflow in Q2 FY25, bolstered by new contract wins worth approximately $28 million and a healthy $110 million contract backlog.

Leo Lithium Limited reports a robust cash position of $269.3 million following the sale of a 40% stake in MLBV, underpinning its financial strength amid ongoing operational expenditures.

Strategic Elements Ltd reports a robust cash position and progress across its portfolio of early-stage ventures, including the promising Energy Ink™ technology and autonomous vehicle applications in mining.

OZZ Resources reports a promising scoping study for its Maguires Reward gold project, highlighting potential positive cash flow despite limited exploration activity during the December 2024 quarter.

Orbital Corporation Ltd reports a strong quarterly update with 29 engines delivered, a debt-free balance sheet, and significant R&D grant funding supporting new engine development.

Titan Minerals Limited has entered an underwriting agreement with CPS Capital Group to cover a $2.8 million options shortfall, ensuring funding for its Dynasty Gold Project and working capital needs.

High Peak Royalties has fully repaid its US$750,000 financing facility with Macquarie Bank, removing all associated securities and guarantees. The company signals confidence in its near-term liquidity and operational funding.

EVE Health Group has completed the sale of its Robyndale tea tree property and relaunched its postbiotic concentrate range, signaling a strategic shift towards innovation and growth in the Australian market.

KneoMedia reports a successful quarter marked by significant capital raises and expanding deployments of its KneoScience platform across New York City schools, positioning the company for sustained revenue growth.

Codeifai Limited has terminated its exclusive licence with MIT and launched a strategic review of its material science division, signaling a decisive pivot towards digital and AI-driven brand solutions.

Avecho Biotechnology progresses its Phase III clinical trial for a TPM®-enhanced CBD insomnia capsule, expands patient recruitment, and completes a major manufacturing campaign for its U.S. partner Ashland.